Can Metformin improve life expectancy in patients with type 2 diabetes? What clinical evidence supports its role in reducing complications and mortality rates associated with diabetes?
Sign Up to our social questions and Answers Engine to ask questions, answer peopleβs questions, and connect with other people.
Please briefly explain why you feel this question should be reported.
Please briefly explain why you feel this answer should be reported.
Please briefly explain why you feel this user should be reported.
1. Metformin is shown to improve life expectancy in type 2 diabetes by reducing complications like heart disease and stroke, supported by large-scale studies like the UKPDS.
2. Clinical evidence from trials such as UKPDS indicates that Metformin not only controls blood glucose but also reduces diabetes-related deaths and cardiovascular events in type 2 diabetics.
3. Research, including the UK Prospective Diabetes Study (UKPDS), shows that Metformin decreases mortality and other complications, thereby potentially increasing life expectancy for type 2 diabetes patients.